Cargando…

Polymicrobial airway bacterial communities in adult bronchiectasis patients

BACKGROUND: Chronic airway infection contributes to the underlying pathogenesis of non-cystic fibrosis bronchiectasis (NCFBr). In contrast to other chronic airway infections, associated with COPD and CF bronchiectasis, where polymicrobial communities have been implicated in lung damage due to the vi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Purcell, Paul, Jary, Hannah, Perry, Audrey, Perry, John D, Stewart, Christopher J, Nelson, Andrew, Lanyon, Clare, Smith, Darren L, Cummings, Stephen P, De Soyza, Anthony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031157/ https://www.ncbi.nlm.nih.gov/pubmed/24886473 http://dx.doi.org/10.1186/1471-2180-14-130

Ejemplares similares

Anti-bacterial antibody and T cell responses in bronchiectasis are differentially associated with lung colonization and disease
por: Jaat, Fathia G., et al.
Publicado: (2018)

A metagenomic approach to characterize temperate bacteriophage populations from Cystic Fibrosis and non-Cystic Fibrosis bronchiectasis patients
por: Tariq, Mohammad A., et al.
Publicado: (2015)

Bronchiectasis Is a Model for Chronic Bacterial Infection Inducing Autoimmunity in Rheumatoid Arthritis
por: Quirke, Anne‐Marie, et al.
Publicado: (2015)

Ecological Succession of Polymicrobial Communities in the Cystic Fibrosis Airways
por: Khanolkar, Rutvij A., et al.
Publicado: (2020)

Multimorbidity in bronchiectasis: a systematic scoping review
por: Marsland, Imogen, et al.
Publicado: (2023)

One versus Many: Polymicrobial Communities and the Cystic Fibrosis Airway
por: Jean-Pierre, Fabrice, et al.
Publicado: (2021)

Family case studies: absence of Pseudomonas aeruginosa transmission in bronchiectasis
por: Sobala, Ruth, et al.
Publicado: (2022)

Temperate Bacteriophages from Chronic Pseudomonas aeruginosa Lung Infections Show Disease-Specific Changes in Host Range and Modulate Antimicrobial Susceptibility
por: Tariq, Mohammad A., et al.
Publicado: (2019)

Protease–Antiprotease Imbalance in Bronchiectasis
por: Oriano, Martina, et al.
Publicado: (2021)

Bronchiectasis Information and Education: a randomised, controlled feasibility trial
por: Hester, Katy L. M., et al.
Publicado: (2020)

Airway clearance treatments in bronchiectasis: feasibility of linking survey results to registry data and a survey of patients’ and physiotherapists’ practices
por: McLeese, Rebecca H., et al.
Publicado: (2023)

Outcomes of lung transplantation in adults with bronchiectasis
por: Birch, Jodie, et al.
Publicado: (2018)

Patient information, education and self-management in bronchiectasis: facilitating improvements to optimise health outcomes
por: Hester, Katy L. M., et al.
Publicado: (2018)

Combined Application of Bacterial Predation and Violacein to Kill Polymicrobial Pathogenic Communities
por: Im, Hansol, et al.
Publicado: (2017)

An evaluation of methods for the isolation of nontuberculous mycobacteria from patients with cystic fibrosis, bronchiectasis and patients assessed for lung transplantation
por: Stephenson, D., et al.
Publicado: (2019)

Development of the Preterm Gut Microbiome in Twins at Risk of Necrotising Enterocolitis and Sepsis
por: Stewart, Christopher J., et al.
Publicado: (2013)

Fighting polymicrobial biofilms in bacterial vaginosis
por: Sousa, Lúcia G. V., et al.
Publicado: (2023)

Evaluation of a novel information resource for patients with bronchiectasis: study protocol for a randomised controlled trial
por: Hester, Katy L. M., et al.
Publicado: (2016)

Airway tapering: an objective image biomarker for bronchiectasis
por: Kuo, Wieying, et al.
Publicado: (2020)

Development of a Polymicrobial Checkerboard Assay as a Tool for Determining Combinatorial Antibiotic Effectiveness in Polymicrobial Communities
por: Black, Caroline, et al.
Publicado: (2023)

Acute polymicrobial airway infections: analysis in cystic fibrosis mice
por: Lindgren, Natalie R., et al.
Publicado: (2023)

The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO
por: Stockley, Robert A., et al.
Publicado: (2023)

Aberrant Epithelial Cell Proliferation in Peripheral Airways in Bronchiectasis
por: Peng, Yang, et al.
Publicado: (2020)

Bronchoscopic airway clearance therapy for acute exacerbations of bronchiectasis
por: Liu, Yang, et al.
Publicado: (2021)

Measuring airway clearance outcomes in bronchiectasis: a review
por: Franks, Lisa J., et al.
Publicado: (2020)

Airway clearance technique in the modern era of bronchiectasis management
por: Pan, Cui-Xia, et al.
Publicado: (2023)

Multiple breath washout in bronchiectasis clinical trials: is it feasible?
por: O'Neill, Katherine, et al.
Publicado: (2020)

Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung
por: Hilliam, Yasmin, et al.
Publicado: (2017)

Subacute Polymicrobial Bacterial Pericarditis Mimicking Tuberculous Pericarditis: A Case Report
por: Carmack, Anna E., et al.
Publicado: (2021)

On Dilatation of the Bronchi, or Bronchiectasis
por: Stewart, T. Grainger
Publicado: (1867)

British Thoracic Society guideline for bronchiectasis in adults
por: Hill, Adam T, et al.
Publicado: (2018)

Airway disease: similarities and differences between asthma, COPD and bronchiectasis
por: Athanazio, Rodrigo
Publicado: (2012)

Reproducibility of an airway tapering measurement in computed tomography with application to bronchiectasis
por: Quan, Kin, et al.
Publicado: (2019)

Non-antimicrobial airway management of non-cystic fibrosis bronchiectasis
por: Egan, Ashley M., et al.
Publicado: (2017)

Decreased Systemic and Airway Sirtuin 1 Expression in Adults With Bronchiectasis
por: Han, Xiao-rong, et al.
Publicado: (2022)

Bronchiectasis, the Latest Eosinophilic Airway Disease: What about the Microbiome?
por: Singh, Dave, et al.
Publicado: (2022)

Bronchiectasis in severe asthma is associated with eosinophilic airway inflammation and activation
por: Frøssing, Laurits, et al.
Publicado: (2022)

Patient attitudes to nebulised antibiotics in the treatment of bronchiectasis: a mixed-methods study
por: Davison, John, et al.
Publicado: (2023)

Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study
por: Wilson, Robert, et al.
Publicado: (2013)

Inspiratory Flows and Volumes in Subjects with Non-CF Bronchiectasis Using a New Dry Powder Inhaler Device
por: Elkins, Mark R., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bt9ondommdi3udll7dhoocrao8